Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

Global cancer immunotherapy sales share by type 2021 forecast

Published by Statista Research Department, Mar 14, 2016
This statistic depicts the market share forecast for top immuno-oncology companies worldwide in 2021. By 2021, it is predicted that Bristol-Myers Squibb will account for 34 percent of immuno-oncology sales worldwide.

Market share forecast for top immuno-oncology companies worldwide in 2021*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2016

Region

Worldwide

Survey time period

as of March 2016

Supplementary notes

* Based on sales. Immuno-oncology sales comprises immune checkpoint inhibitors, therapeutic vaccines, oncolytic viral therapy, and T cell therapy (tumor-targeted mAbs excluded).
** Merck KGaA-Pfizer alliance to co-develop and co-commercialize PD-L1 inhibitor, avelumab.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Oncology "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Oncology

Cancer facts

5

Oncology market

6

Companies

7

Cancer drugs

5

Research and development

6

Immuno-oncology

5

Treatment types

5

Physicians and patients

8

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

RocheGlobal pharmaceutical industryJohnson & JohnsonNovartisCancer in the U.S.
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu